Clinical Trial Update: 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Mahidol University is evaluating long-term outcomes 10 years after a single-dose acellular pertussis vaccination, and recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Acellular pertussis vaccine (acellular pertussis vaccine)

Snippet

Sponsor: Mahidol University | Conditions: Pertussis | Phase 4 | Status: RECRUITING